If you join, you will first complete a short online survey to see if you qualify. If you qualify, you will then have either an in person or online visit that will take about 30 minutes, to learn about the study and sign a consent form either on paper or through a secure online system. If you qualify, you will come to the Clinical Translational Research Center (CTRC) at the Anschutz Medical Campus for two visits. The first visit lasts about 2 hours. You will need to fast for 4 hours and avoid caffeine, exercise, and some medications before coming. During this visit, you will have a physical exam, give a blood sample, fill out health and lifestyle questionnaires, take a memory test, and get some scans to measure body fat, muscle, and hand strength. You’ll also receive food diaries to record everything you eat and drink for three days. The second visit lasts about 3 hours. You will return the food diaries and have more blood and blood pressure tests. We will test how your arteries, heart, and brain blood flow work using ultrasound and sensors while you lie down. There is also an optional test to collect cells from inside your veins. You will be paid up to $100 total for each completed visit, $40 for the first visit, and $60 for the second. If you leave the study early, you will be paid for the visits you completed.

Who can Participate

To join this study, you must be 18 years or older, and either a lymphoma survivor or a healthy adult. If you are a survivor, you need to be at least 4 weeks past your last doxorubicin-containing chemotherapy treatment. You cannot be pregnant or breastfeeding. You must not have used hormone therapy in the past 12 months, and you should not have taken MitoO or CoQ10 supplements in the last month.

Study ID

More information available at ClinicalTrials.gov: NCT00000000